Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Monogram Orthopaedics Inc. (MGRM : NSDQ)

• Company Description    Monogram Orthopedics is involved in developing patient-optimized, 3D-printed orthopedic implants enabled by robotics with advanced pre-operative imaging. Monogram Orthopedics is based in AUSTIN, TX. Number of Employees: 27

• Price / Volume Information    Yesterday's Closing Price: $3.29 Daily Weekly Monthly 20 Day Moving Average: 57,843 shares Shares Outstanding: 35.69 (millions) Market Capitalization: $117.41 (millions) Beta: 0.59 52 Week High: $4.21 52 Week Low: $1.92 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 23.68% 18.10% 12 Week 21.85% 2.83% Year To Date 38.82% 30.43%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3913 Todd Lane - Austin,TX 78744 USA ph: 512-399-2656 fax: - mgrm@mzgroup.us http://www.monogramtechnologies.com

• General Corporate Information    Officers Benjamin Sexson - Chief Executive Officer;President;Principal Execut Noel Knape - Chief Financial Officer; Principal Financial Offic Douglas Unis - Director Colleen Gray - Director Paul Riss - Director Peer Information Monogram Orthopaedics Inc. (ABMD) Monogram Orthopaedics Inc. (DMDS) Monogram Orthopaedics Inc. (CPWY.) Monogram Orthopaedics Inc. (EQUR) Monogram Orthopaedics Inc. (ECIA) Monogram Orthopaedics Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 609786108 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/13/25 Share - Related Items Shares Outstanding: 35.69 Most Recent Split Date: (:1) Beta: 0.59 Market Capitalization: $117.41 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.12 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.60 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 9.94 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 9.09% vs. Previous Quarter: -25.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - -115.71 12/31/24 - -121.73 ROA 06/30/25 - - 03/31/25 - -92.75 12/31/24 - -99.19 Current Ratio 06/30/25 - - 03/31/25 - 7.00 12/31/24 - 10.57 Quick Ratio 06/30/25 - - 03/31/25 - 7.00 12/31/24 - 10.57 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 0.33 12/31/24 - 0.42 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©